{
 "drug": "Sodium Acetate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "02/03/2016",
 "dayN": 3856,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Hikma Pharmaceuticals USA, Inc.",
  "Fresenius Kabi USA, LLC",
  "Somerset Therapeutics, LLC",
  "Milla Pharmaceuticals"
 ],
 "reasons": [
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-7299-25",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "1859490"
    ],
    "spl_id": [
     "013001c4-5584-4d8c-8bf6-917d2a919aa4",
     "10c75a24-9542-431a-84f8-44611bc916df"
    ],
    "spl_set_id": [
     "ce9a7469-c4ba-4f60-8f7a-47ef0974316e",
     "c91ede49-c7cc-47b7-0f93-e6841dd5916a"
    ],
    "package_ndc": [
     "0409-7299-45",
     "0409-7299-25",
     "0409-7299-83",
     "0409-7299-73"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0641-6261-01",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots will be available. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA216920"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6261"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "1859490"
    ],
    "spl_id": [
     "3493d4c1-4f73-44e8-94bc-7b55fe4fd436"
    ],
    "spl_set_id": [
     "8a338072-6f1e-460c-b9ec-59cef4f3f597"
    ],
    "package_ndc": [
     "0641-6261-01"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/23/2016",
   "package_ndc": "63323-032-00",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA206687"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-032"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE"
    ],
    "rxcui": [
     "312965"
    ],
    "spl_id": [
     "37c19fc5-c1ce-4ea0-9cba-4cdf32112091"
    ],
    "spl_set_id": [
     "d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b"
    ],
    "package_ndc": [
     "63323-032-04",
     "63323-032-00"
    ],
    "unii": [
     "4550K0SC9B"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "70069-048-20",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA219826"
    ],
    "brand_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "generic_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-048",
     "70069-047"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "1aae3237-9555-442b-b962-619d23f7e00a"
    ],
    "spl_set_id": [
     "93edebd6-ef7f-483a-80b6-bfaf34ea5ded"
    ],
    "package_ndc": [
     "70069-047-25",
     "70069-048-20"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-3299-05",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "4e6137c2-6b7c-4882-985c-03b591b6c046",
     "b7a713f4-3c97-484b-b182-2824e1e944bb"
    ],
    "spl_set_id": [
     "abc41ed1-9512-4bea-9295-1a9ca134b6c2",
     "c3be2468-45e8-4ecc-a30b-e966743a563f"
    ],
    "package_ndc": [
     "0409-3299-15",
     "0409-3299-05",
     "0409-3299-16",
     "0409-3299-06",
     "0409-3299-45",
     "0409-3299-25",
     "0409-3299-46",
     "0409-3299-26"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0641-6262-01",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots will be available.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA216920"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6262",
     "0641-6263"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "777b7564-f07b-401a-a042-0cd512ae3b25"
    ],
    "spl_set_id": [
     "7ee23a1c-bc99-4ff6-b2e7-d2aa42744553"
    ],
    "package_ndc": [
     "0641-6262-01",
     "0641-6263-01",
     "0641-6263-10"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-7299-73",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "1859490"
    ],
    "spl_id": [
     "013001c4-5584-4d8c-8bf6-917d2a919aa4",
     "10c75a24-9542-431a-84f8-44611bc916df"
    ],
    "spl_set_id": [
     "ce9a7469-c4ba-4f60-8f7a-47ef0974316e",
     "c91ede49-c7cc-47b7-0f93-e6841dd5916a"
    ],
    "package_ndc": [
     "0409-7299-45",
     "0409-7299-25",
     "0409-7299-83",
     "0409-7299-73"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "71357-002-10",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "833-251-8463",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214805"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "MILLA PHARMACEUTICALS INC."
    ],
    "product_ndc": [
     "71357-002"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE"
    ],
    "rxcui": [
     "1859490"
    ],
    "spl_id": [
     "2bdf8f55-9a63-bff7-e063-6394a90aafd0"
    ],
    "spl_set_id": [
     "1ea04916-78e5-4651-e063-6394a90ac4be"
    ],
    "package_ndc": [
     "71357-002-01",
     "71357-002-10"
    ],
    "unii": [
     "4550K0SC9B"
    ]
   },
   "update_date": "08/15/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)",
   "company_name": "Milla Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "71357-009-10",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "833-251-8463",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA214805"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE INJECTION, USP, 400 MEQ/100 ML"
    ],
    "manufacturer_name": [
     "MILLA PHARMACEUTICALS INC."
    ],
    "product_ndc": [
     "71357-009",
     "71357-007",
     "71357-008"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE"
    ],
    "rxcui": [
     "237371",
     "312965"
    ],
    "spl_id": [
     "47d8d0e7-6db5-950d-e063-6294a90ab1bf"
    ],
    "spl_set_id": [
     "1ea1466d-a492-4056-e063-6394a90a80bf"
    ],
    "package_ndc": [
     "71357-007-01",
     "71357-007-10",
     "71357-008-01",
     "71357-008-10",
     "71357-009-01",
     "71357-009-10"
    ],
    "unii": [
     "4550K0SC9B"
    ]
   },
   "update_date": "08/15/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)",
   "company_name": "Milla Pharmaceuticals",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/23/2016",
   "package_ndc": "71357-008-10",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "833-251-8463",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214805"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE INJECTION, USP, 200 MEQ/100 ML"
    ],
    "manufacturer_name": [
     "MILLA PHARMACEUTICALS INC."
    ],
    "product_ndc": [
     "71357-008",
     "71357-007",
     "71357-009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE"
    ],
    "rxcui": [
     "237371",
     "312965"
    ],
    "spl_id": [
     "47d8d0e7-6db5-950d-e063-6294a90ab1bf"
    ],
    "spl_set_id": [
     "1ea1466d-a492-4056-e063-6394a90a80bf"
    ],
    "package_ndc": [
     "71357-007-01",
     "71357-007-10",
     "71357-008-01",
     "71357-008-10",
     "71357-009-01",
     "71357-009-10"
    ],
    "unii": [
     "4550K0SC9B"
    ]
   },
   "update_date": "08/15/2026",
   "therapeutic_category": [
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)",
   "company_name": "Milla Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-3299-06",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Next Delivery and Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "4e6137c2-6b7c-4882-985c-03b591b6c046",
     "b7a713f4-3c97-484b-b182-2824e1e944bb"
    ],
    "spl_set_id": [
     "abc41ed1-9512-4bea-9295-1a9ca134b6c2",
     "c3be2468-45e8-4ecc-a30b-e966743a563f"
    ],
    "package_ndc": [
     "0409-3299-15",
     "0409-3299-05",
     "0409-3299-16",
     "0409-3299-06",
     "0409-3299-45",
     "0409-3299-25",
     "0409-3299-46",
     "0409-3299-26"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/23/2016",
   "package_ndc": "71357-007-10",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "833-251-8463",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214805"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "MILLA PHARMACEUTICALS INC."
    ],
    "product_ndc": [
     "71357-007",
     "71357-008",
     "71357-009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE"
    ],
    "rxcui": [
     "237371",
     "312965"
    ],
    "spl_id": [
     "47d8d0e7-6db5-950d-e063-6294a90ab1bf"
    ],
    "spl_set_id": [
     "1ea1466d-a492-4056-e063-6394a90a80bf"
    ],
    "package_ndc": [
     "71357-007-01",
     "71357-007-10",
     "71357-008-01",
     "71357-008-10",
     "71357-009-01",
     "71357-009-10"
    ],
    "unii": [
     "4550K0SC9B"
    ]
   },
   "update_date": "08/15/2026",
   "therapeutic_category": [
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)",
   "company_name": "Milla Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-3299-26",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "4e6137c2-6b7c-4882-985c-03b591b6c046",
     "b7a713f4-3c97-484b-b182-2824e1e944bb"
    ],
    "spl_set_id": [
     "abc41ed1-9512-4bea-9295-1a9ca134b6c2",
     "c3be2468-45e8-4ecc-a30b-e966743a563f"
    ],
    "package_ndc": [
     "0409-3299-15",
     "0409-3299-05",
     "0409-3299-16",
     "0409-3299-06",
     "0409-3299-45",
     "0409-3299-25",
     "0409-3299-46",
     "0409-3299-26"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "0409-3299-25",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018893"
    ],
    "brand_name": [
     "SODIUM ACETATE"
    ],
    "generic_name": [
     "SODIUM ACETATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3299"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "4e6137c2-6b7c-4882-985c-03b591b6c046",
     "b7a713f4-3c97-484b-b182-2824e1e944bb"
    ],
    "spl_set_id": [
     "abc41ed1-9512-4bea-9295-1a9ca134b6c2",
     "c3be2468-45e8-4ecc-a30b-e966743a563f"
    ],
    "package_ndc": [
     "0409-3299-15",
     "0409-3299-05",
     "0409-3299-16",
     "0409-3299-06",
     "0409-3299-45",
     "0409-3299-25",
     "0409-3299-46",
     "0409-3299-26"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "02/03/2016",
   "package_ndc": "70069-047-25",
   "generic_name": "Sodium Acetate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA219826"
    ],
    "brand_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "generic_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-047",
     "70069-048"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM ACETATE ANHYDROUS"
    ],
    "rxcui": [
     "237371"
    ],
    "spl_id": [
     "1aae3237-9555-442b-b962-619d23f7e00a"
    ],
    "spl_set_id": [
     "93edebd6-ef7f-483a-80b6-bfaf34ea5ded"
    ],
    "package_ndc": [
     "70069-047-25",
     "70069-048-20"
    ],
    "unii": [
     "NVG71ZZ7P0"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  }
 ]
}